(1) Loh E, Sutton MSJ, Wun C-CC, Rouleau JL, Flaker GC, Gottlieb SS, et al. Ventricular Dysfunction and the Risk of Stroke after Myocardial Infarction. N. Engl. J. Med. 1997;336:251–257. Available from: http://www.nejm.org/doi/abs/10.1056/NEJM199701233360403
(2) Ntaios G, Vemmos K, Lip GYH. Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials. Int. J. Stroke. 2019; 14:856–861. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31526132